1. | rlmcdonough | |
2. | animegamer7947 | |
3. | m4collector | |
4. | kenenthedmonds | |
5. | celeste2096 |
1. | rlmcdonough | |
2. | animegamer7947 | |
3. | m4collector | |
4. | kenenthedmonds | |
5. | celeste2096 |
1. | m4collector 06/21/2018 BeyondSpring Provides Operational Updates and First-Quarter 2018 Financial Results |
2. | animegamer7947 02/07/2018 Summarizes Key Messages |
3. | lostcause47999 01/26/2018 Presents 'promising' data for lead asset Plinabulin |
4. | animegamer7947 01/26/2018 what happened today!!!!! |
5. | celeste2096 04/03/2018 Maxim Group reiterates Buy rating, $52 PT |
6. | kenenthedmonds 01/18/2018 Let's top the bleeding here |
7. | kenenthedmonds 04/25/2018 Files for 5 mln ordinary share offering |
8. | rlmcdonough 04/03/2018 BeyondSpring Provides Operational Update and Fourth-Quarter and Full-Year 2017 Financial Results |
9. | lostcause47999 01/18/2018 Attention: - BeyondSpring to Present Data from Phase 2 Portion of Study 105 Phase 2/3 Trial with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia at 2018 ASCO-SITC Clinical |